Maybe I have missed it as I get bored to tears flipping through the interminable posts on self sustaining something and all the other reasons why MSB is a spent force but has there been any discussion at all on AbbeVie's gaining FDA approval for their cGVHD product Imbruvica (acquired from Pharmacyclics at an implied value of $42bn a few years back?) Sales for the first 2 quarters were over $1bn. I understand the difference between cGVHD and aGVHD but wondered what the view from this forum may be.
Maybe I have missed it as I get bored to tears flipping through...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.101B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 99.5¢ | 96.0¢ | $2.283M | 2.340M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29300 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |